Device Makers Want Say In Medicare 'Coverage-With-Evidence-Development' Policy
This article was originally published in The Gray Sheet
Manufacturers seek more input on trial designs and objectives when CMS takes the "coverage-with-evidence-development" route to national Medicare coverage.
You may also be interested in...
Minimally Invasive Spine Technique Gets Second Look By CMS
The Medicare agency is reconsidering coverage of percutaneous image-guided lumbar decompression for lumbar spine stenosis in response to a request by device manufacturer Vertos. The firm's goal is to lift current clinical trial conditions for coverage of the procedure.
CMS Ambiguous On Role Of Local Contractors In Coverage With Evidence Development
Activities by Medicare contractors were among several matters that were addressed in CMS’ recent CED draft guidance that may not be fully clarified until the updated guidelines are put into practice, experts say.
A “Fine Line:” CMS’ Jacques On Coverage-With-Evidence Requirements
Medicare coverage director Louis Jacques describes the necessary balancing act to gauge the appropriate level of data requirements for a coverage-with-evidence-development policy.